Global Weight Loss Market Size, Share, Trends & Forecast (2026-2036) Featuring Novo Nordisk, Boehringer Ingelheim, Herbalife, WW Int'l, Medtronic and More | GLP-1 Drugs, Oral Therapies, Coverage,

What happened: ResearchAndMarkets added a global weight loss market report forecasting growth to USD 244.00 billion by 2036, covering GLP-1 drugs, oral therapies, telehealth, and nutrition. Key numbers: Market valued at USD 97.50 billion in 2025, estimated at USD 113.00 billion in 2026, reaching USD 244.00 billion by 2036 at an 8.0% CAGR. Why it matters: Pharmacotherapy is forecast for the highest CAGR while devices and surgical products expand more slowly as drugs substitute for some procedures. Public reimbursement and oral therapies are cited as key catalysts for broader access. Market: +7.1% today ($187.40), +3.4% YTD, 1.0x vol — as of 16:32 UTC

ResearchAndMarkets added a global weight loss market report forecasting growth to USD 244.00 billion by 2036, covering GLP-1 drugs, oral therapies, telehealth, and nutrition.

Pharmacotherapy is forecast for the highest CAGR while devices and surgical products expand more slowly as drugs substitute for some procedures. Public reimbursement and oral therapies are cited as key catalysts for broader access. Market: +7.1% today ($187.40), +3.4% YTD, 1.0x vol — as of 16:32 UTC